Abiopharma

News list

Schjotz Gitte 🟡 adjusted position in 0 shares (1 derivative) of UL Solutions Inc. (ULS) Transaction Date: May 01, 2026 | Filing ID: 002105

Full text

News bot May 5, 2026, 9:58 p.m.
🔍 Schjotz Gitte (Executive)

Company: UL Solutions Inc. (ULS)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,755
- Total shares sold: 2,755
Detailed Transactions and Holdings:
- Acquired 2,755 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | shares_owned_after: 73,251.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,755 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | shares_owned_after: 2,762.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2: The restricted stock units vest in three equal installments on the first, second and third anniversaries of May 1, 2024.
- F3: Includes restricted stock units and all dividend equivalent rights that have accrued on such restricted stock units to date.
- REMARKS: Executive Vice President, Chief Business Operations and Innovation Officer